SCHEMBL29645010

SCHEMBL29645010

Fc1ccccc1-c1cc(NCc2ccncc2)n2nccc2n1

nearest known ligand 0.70

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 14/20 0.70
GSK3B P49841 2/20 0.60
KCNN3 Q9UGI6 4/20 0.53
KCNN1 Q92952 2/20 0.53
KCNN2 Q9H2S1 2/20 0.53
CCNE1 P24864 5/20 0.53
CCNA2 P20248 1/20 0.49
CCNA1 P78396 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12953673 1.00 CDK2 (0.70) CDK2GSK3BKCNN3KCNN1KCNN2
SCHEMBL13304765 0.84 CDK2 (0.77) CDK2GSK3BCCNE1CCNA2CCNA1
SCHEMBL13998577 0.83 GSK3B (0.57) CDK2GSK3BCCNE1CCNA2CCNA1
SCHEMBL12953328 0.82 CDK2 (1.00) CDK2GSK3BCCNE1CCNA2CCNA1
SCHEMBL12953495 0.82 CDK2 (1.00) CDK2GSK3BCCNE1CCNA2CCNA1
SCHEMBL12953444 0.82 CDK2 (0.62) CDK2GSK3BKCNN3KCNN1KCNN2
SCHEMBL12953671 0.81 CDK2 (0.76) CDK2GSK3BCCNE1CCNA2CCNA1
SCHEMBL14418795 0.78 CDK2 (0.58) CDK2GSK3BKCNN3KCNN1KCNN2
SCHEMBL14565183 0.76 CDK2 (0.72) CDK2GSK3BCCNE1CCNA2CCNA1
SCHEMBL5454018 0.76 CDK2 (0.67) CDK2KCNN3KCNN1KCNN2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4256086-A1 METHODS AND SYSTEMS OF STRATIFYING INFLAMMATORY DISEASE PATIENTS Cedars-Sinai Medical Center (US) 2023-10-11 EP disclosed
EP-4162076-A1 TREATMENTS FOR A SUB-POPULATION OF INFLAMMATORY BOWEL DISEASE PATIENTS Cedars-Sinai Medical Center (US) 2023-04-12 EP disclosed
WO-2022119842-A1 METHODS AND SYSTEMS OF STRATIFYING INFLAMMATORY DISEASE PATIENTS CEDARS-SINAI MEDICAL CENTER (US) 2022-06-09 WO disclosed